For President-elect Donald Trump, fixing the healthcare insurance problem also includes finding ways to reduce prescription drug costs which means dealing with “Big Pharma,” pharmaceutical companies with huge lobbies that negotiate with the federal government for larger profits.
Donald Trump has vowed to repeal Obama’s signature healthcare program, the Affordable Care Act, and now he hopes to institute new bidding procedures for the pharmaceutical industry to which, Speaker of the House, Paul Ryan has taken issue.
The Speaker of the House of Representatives, failed one-time GOP vice presidential candidate Paul Ryan, is picking a fight with incoming President Donald J. Trump and Vice President Mike Pence over the Trump administration’s vow to tackle corruption in Big Pharma.
Trump promised during his press conference in New York City at Trump Tower last week to reform the pharmaceutical industry to ensure proper bidding procedures take place—among other reforms to the major industry—moving forward.
“We have to get our drug industry coming back,” Trump said at the press conference. “Our drug industry has been disastrous. They’re leaving left and right. They supply our drugs but they don’t make them here, to a large extent. And the other thing we have to do is create new bidding procedures for the drug industry, because they’re getting away with murder. Pharma has a lot of lobbies, a lot of lobbyists, a lot of power. And there’s very little bidding on drugs. We’re the largest buyer of drugs in the world, and yet we don’t bid properly. We’re going to start bidding. We’re going to save billions of dollars over a period of time.”
Trump’s comments sent the pharmaceutical industry, according to Fortune Magazine, into a financial tailspin. So naturally, Ryan–the donor class’s representative in Washington–rode into the rescue and to fight Trump.
Ryan, in response in an interview with Mike Allen of Axios, said that he wants to “have more conversations about” Trump’s efforts to crack down on Big Pharma corruption before the president-elect—soon to be president—does so.
Clearly, Speaker Ryan is moving to protect his benefactors in “Big Pharma,” because they’re most likely responsible for his continuation in office as big donors to his re-election campaign.
This is an example of the very corruption that President-elect Trump is trying to eliminate and we don’t need Paul Ryan second guessing what Trump should be doing.
Ryan needs to get behind Trump and follow his lead!